Use of ciprofloxacin as a prophylactic agent in urinary tract infections in renal transplant recipients

Clinical Transplantation

Volumn 11, Issue 5 I, 1997, Pages 446-452

  Neto, Miguel Moysés ^a,b   Costa, Roberto S ^a   Reis, Marlene A ^a   Ferraz, Agenor S ^a   Saber, Luciana T S ^a   Batista, Maria Estela P N ^a   Muglia, Valmir ^a   Garcia, T M P ^a   Figueiredo, José Fernando C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Ciprofloxacin; Kidney transplantation; Prophylaxis; Urinary tract infection

Indexed keywords

CIPROFLOXACIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION;

EID: 9844227897     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. RUBIN RH, WOLFSON JS, COSIMI AB, TOLKOFF-RUBIN NA. Infection in the renal transplant recipient. Am J Med 1981: 70: 405.
2. RUBIN RH, TOLKOFF-RUBIN NE. The impact of infection on the outcome of transplantation. Transpl Proc 1991: 23: 2068.
3. FIRST MR. Long term complications after transplantation. Am J Kidney Dis 1993: 22: 477.
4. RUBIN RH. Infectious disease complications of renal transplantation. Kidney Int 1993: 44: 221.
5. EICKOFF TC. Infectious complications in renal tranplant recipients. Transpl Proc 1973: 5: 1233.
6. NIELSEN HE, KOIRSAGER B. Bacteremia after renal transplantation. Scand J Infect Dis 1977: 9: 111.
7. PETERSON PK, FERGUSON R, FRYD DS, BALFOUR HH JR, RYANSIEWICZ J, SIMMONS RL. Infectious diseases in hospitalized renal transplant recipients: a prospective study of a complex and evolving problem. Medicine 1982: 61. 360.
8. RUBIN RH. Infection in the renal and liver transplant patient. In: RUBIN RH, YOUNG LS, eds. Clinical approach to infection in the compromised host. 2nd edn. New York: Plenum Medical, 1988.
9. MAKI DG, Fox BC, KUNTZ J, SOLLINGER HW, BELZER FO. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxasole for prophylaxis of infection in renal transplantation.Side effects of trimethoprim-sulfamethoxasole, interaction with cyclosporine. J Lab Clin Med 1992: 119: 11.
10. Fox BC, SOLLINGER HW, BELZER FO. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxasole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxasole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 1990: 89: 253.
11. HIBBERD PL, TOLKOFF-RUBIN NE, DORAN M, et al. Trimethoprim-sulfamethoxasole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial. Online J Curr Clin Trials; Doc No. 15, 1992.
12. WAGENER M, Yu VL. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors and outcomes. Am J Inf Control 1992: 20: 239.
13. WEBSTER A, GAYA H. Quinolones in the treatment of serious infections. Rev Inf Dis 1988: 10 (suppl. 1): S225.
14. SANDERS CC, SANDERS WE, GOERING RV. Overview of preclinical studies with ciprofloxacin. Am J Med 1987: 82 (suppl. 4A): 2.
15. YOUNG LS, BERLIN OGW, INDERLIED CB. Activity of ciprofloxacin and other fluorinated quinolones against Mycobacteria. A J Med 1987: 82 (suppl. 4A): 23.
16. GREKAS D, THANOS V, ALIVANIS P, TOURKANTONIS A. Treatment of urinary tract infections with ciprofloxacin after renal transplantation. Int J Clin Pharmacol Ther Toxicol 1993: 31: 309.
17. WALL EVD, VERKOOYEN RP, GROOT JM, OOSTINGA J, DIJK AV, HUSTINX WNM, VERBRUGH HA. Prophylatic ciprofloxacin for catheter-associated urinary-tract infection. Lancet 1992: 339: 946.
18. BIERING-SORENSEN, HOIBY V, NORDENBO A, RAVNBORG M, BRUUN B, RAHM V. Ciprofloxacin as prophylaxis for urinary tract infection; a prospective, randomized, crossover, placebo controlled study in patients with spinal cord lesion. J Urol 1994: 151: 105.
19. POBLETE GH, MORALES JM, PRIETOA AA, ORTUN̄OT RJL. Usefulness of norfloxacin prophylaxis in late recurrent urinary tract infection after renal transplantation. Nephron 1990: 54: 193.
20. LANG J, FINAZ DE VILLAINE J, GARRAFO R, TOURAINE JL. Cyclosporine (cyclosporin A) pharmacokinetics in renal transplant patients receiving ciprofloxacin. Am J Med 1989: 87 (suppl. 5A): 82.
21. MOYSÉS NETO M, MUGLIA V, BATISTA MEPN, et al. Infecçäo por fungos e transplante renal: Análise nos primeiros 500 pacientes transplantados no Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto-USP. J Bras Nefrol 1995: 17: 162.
22. ODDS FC. Candida and Candidosis. A review and bibliography, 2nd ed. London. Bailliere Tindal, 1988: p. 169.
23. PAYA CV. Fungal Infections in solid-organ transplantation. Clin Inf Dis 1993. 16: 677.
24. ANG BSP, TELENTI A, KING B, STECKELBERG JM, WILSON WR. Candidemia from a urinary tract source: microbiological aspects and clinical significance. Clin Inf Dis 1993: 17: 662.
25. THOMALLA JV, STEIDLE CP, LEAPMAN SB, FILO RS. Ureteral obstruction of a renal allograft secondary to Candida krusei. Transpl Proc 1988: 20: 551.